期刊
EPILEPSIA
卷 53, 期 7, 页码 e115-e118出版社
WILEY
DOI: 10.1111/j.1528-1167.2012.03492.x
关键词
Transcutaneous vagus nerve stimulation; Pharmacoresistant epilepsies; Outpatient monitoring; Automatic seizure quantification; Computerized cognitive testing in epilepsy; Neuromodulation; Neurostimulation; EEG
资金
- Cerbomed (Erlangen, Germany)
To elucidate, in a pilot-study, whether noninvasive transcutaneous vagus nerve stimulation (t-VNS) is a safe and tolerable alternative treatment option in pharmacoresistant epilepsy. t-VNS was applied to 10 patients with pharmacoresistant epilepsies. Stimulation via the auricular branch of the vagus nerve of the left tragus was delivered three times per day for 9 months. Subjective documentation of stimulation effects was obtained from patients seizure diaries. For a more reliable assessment of seizure frequency, we carried out prolonged outpatient videoelectroencephalography (EEG) monitoring. In addition, computerized testing of cognitive, affective, and emotional functions was performed. Three patients aborted the study. Of the remaining seven patients, an overall reduction of seizure frequency was observed in five patients after 9 months of t-VNS. The noninvasive t-VNS stimulation is a safe and well-tolerated method for relatively long periods, and might be an alternative treatment option for patients with epilepsy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据